PRKAA2 and nasopharyngeal carcinoma: Taken together, the current study illustrates a molecular and signal pathway basis for better understanding of how KISS1/KISS1R alters LKB1 activation and thereby activates the AMPK signaling pathway, ultimately inhibits the proliferation of nasopharyngeal carcinoma.